Glucose Levels as a Biomarker for Stress in Firefighters
Launched by UNIVERSITY OF UTAH · Mar 20, 2025
Trial Information
Current as of November 14, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a small, observational study at the University of Utah to see if firefighters’ stress during emergency calls shows up in their blood sugar. About 17 full-time firefighters from the Unified Fire Authority will be followed for roughly two weeks. To be eligible, adults must be full-time firefighters on a study-designated crew, not have diabetes or use insulin, and not regularly take certain medicines like steroids, antibiotics, or benzodiazepines. Participation is by invitation.
During the study, participants will wear a continuous glucose monitor that records glucose every minute, 24/7, on both work shifts and days off. They will also rate how stressed they feel during calls and identify the three most stressful calls on shift and off shift. Researchers will compare glucose changes around emergency dispatches with these stress ratings to learn whether stress is linked to the body's stress response. This is an observational study with no treatment involved, and results are intended to inform future research on firefighter health. The study is not FDA-regulated and is planned to complete in early 2025.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Full time Unified Fire Authority (UFA) employee working for a fire crew that has been designated by the UFA board as approved for study participation
- Exclusion Criteria:
- • Use of insulin
- • Diagnosed with Diabetes Mellitus
- • Practicing a ketoacidosis or intermittent fasting diet
- • Intermittent use of glucocorticoids, antibiotics or benzodiazepines
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Matthew Thiese, PhD
Principal Investigator
matt.thiese@hsc.utah.edu
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported